Skip to main content
Shota Yamamoto, MD, Radiology, Chula Vista, CA, San Joaquin General Hospital

ShotaYamamotoMD

Radiology Chula Vista, CA

Neuroradiology

Physician

Dr. Yamamoto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Yamamoto's full profile

Already have an account?

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiology-Diagnostic, 2013 - 2017
  • University of California (San Francisco) School of Medicine
    University of California (San Francisco) School of MedicineInternship, Transitional Year, 2011 - 2012
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2011

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2019 - 2026
  • HI State Medical License
    HI State Medical License 2019 - 2026
  • IN State Medical License
    IN State Medical License 2019 - 2025
  • TX State Medical License
    TX State Medical License 2017 - 2025
  • OH State Medical License
    OH State Medical License 2017 - 2025
  • WI State Medical License
    WI State Medical License 2019 - 2025
  • MO State Medical License
    MO State Medical License 2019 - 2025
  • American Board of Radiology Diagnostic Radiology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • The Impact of Bronchial Artery Embolisation on the Quality of Life of Patients with Haemoptysis: A Prospective Observational Study
    The Impact of Bronchial Artery Embolisation on the Quality of Life of Patients with Haemoptysis: A Prospective Observational StudyJanuary 6th, 2021
  • Impact of the Catechol-O-methyltransferase Val158Met Polymorphism on the Pharmacokinetics of L-dopa and Its Metabolite 3-O-methyldopa in Combination with Entacapone
    Impact of the Catechol-O-methyltransferase Val158Met Polymorphism on the Pharmacokinetics of L-dopa and Its Metabolite 3-O-methyldopa in Combination with EntacaponeNovember 2nd, 2020
  • The Co-Creator of Prey, Duke Nukem, and Max Payne Wants to Kill You with Vitamin Supplements
    The Co-Creator of Prey, Duke Nukem, and Max Payne Wants to Kill You with Vitamin SupplementsOctober 5th, 2017

Hospital Affiliations